Study GL94-01: Corticosteroid Reduction Individual Patient Example of Prednisone Dose Change from Baseline to Last Visit (30287)

4/20/01


Click here to start


Table of Contents

Study GL94-01: Corticosteroid Reduction Individual Patient Example of Prednisone Dose Change from Baseline to Last Visit (30287)

Study GL94-01: Corticosteroid Reduction Individual Patient Example of Prednisone Dose Change from Baseline to Last Visit (28242)

Study GL94-01: Corticosteroid Reduction Individual Patient Example of Prednisone Dose Change from Baseline to Last Visit (24275)

Study GL94-01: Corticosteroid Reduction Individual Patient Example of Prednisone Dose Change from Baseline to Last Visit (20221)

Study GL94-01: Corticosteroid Reduction Individual Patient Example of Prednisone Dose Change from Baseline to Last Visit (18140)

Study GL94-01: Corticosteroid Reduction Individual Patient Example of Prednisone Dose Change from Baseline to Last Visit (18130)

Study GL94-01: Corticosteroid Reduction Individual Patient Example of Prednisone Dose Change from Baseline to Last Visit (13103)

Study GL95-02: Patients Reclassified as Responders When a 3% of the Patient’s Baseline Value “Window” is Used

Patients Whose Responder Status is Changed by Window (N = 67)*

Study GL95-02 Androgenic AES and Responders

Study GL95-02 Percent Change in Bone Density (gm/cm2) by Baseline Prednisone Dose

Correlation of SLAM vs. SLEDAI Baseline and Change from Baseline

Study GL95-02 SLE Serologies (mean/median)

Studies GL94-01 and GL95-02 Responder1 Rate by Race

Study GL96-02 Mean Peak Cortisol (ng/ml)

Adrenal Steroid Pathways

Mean Urinary Free Cortisol (mg/24 hours) Jusko Laboratory

Effects of Dexamethasone on Serum Cortisol in Normal Women

Effects of Dexamethasone on Serum Cortisol in Normal Women

Author: rz90099